Phenanthridine

Phenanthridine

SCHEMBL27628907

OCc1cc2c3c(ccc2c2ccccc12)CCCC3.c1ccc2c(c1)cnc1ccccc12

nearest known ligand 0.47

Full drug profile on Sugi Atlas →

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 1/20 0.47
▸ GPR3 P46089 1/20 0.47
▸ NQO1 P15559 3/20 0.35
▸ KIF11 P52732 1/20 0.33
▸ HTR3E A5X5Y0 1/20 0.33
▸ HTR3B O95264 1/20 0.33
▸ HTR3A P46098 1/20 0.33
▸ HTR3D Q70Z44 1/20 0.33
▸ HTR3C Q8WXA8 1/20 0.33
▸ CHRNE Q04844 1/20 0.33
▸ SELP P16109 1/20 0.32
▸ TOP2A P11388 1/20 0.32
▸ CTSC P53634 1/20 0.32
▸ TRPM8 Q7Z2W7 1/20 0.32
▸ NR3C1 P04150 1/20 0.32
▸ BCHE P06276 1/20 0.32
▸ ACHE P22303 1/20 0.32
▸ MEN1 O00255 1/20 0.32
▸ KMT2A Q03164 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phenanthridine SCHEMBL27628928 0.89 KDM4E (0.44) KDM4EGPR3NQO1KIF11HTR3E
Phenanthridine SCHEMBL27966445 0.84 KDM4E (0.56) KDM4EGPR3KIF11HTR3EHTR3B
SCHEMBL28199787 0.83 KIF11 (0.44) NQO1KIF11CHRNESELPMEN1
Piperazine SCHEMBL27836342 0.77 KIF11 (0.42) NQO1KIF11CHRNE
SCHEMBL17409929 0.77 KIF11 (0.43) KDM4EGPR3KIF11HTR3EHTR3B
SCHEMBL7901266 0.73 KIF11 (0.42) KDM4EGPR3NQO1KIF11HTR3E
Anthracene SCHEMBL28161518 0.72 GNG2 (0.43) KDM4ENQO1KIF11SELPMEN1
Naphthalen-1-Yl-Methanol SCHEMBL27558894 0.72 NQO1 (0.50) NQO1KIF11CHRNEACHE
Benzyl Alcohol SCHEMBL27453002 0.72 NQO1 (0.41) NQO1KIF11ACHE
SCHEMBL27584193 0.71 GNG2 (0.47) KDM4ENQO1KIF11SELPMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102964347-B 8-[3-amino-piperadine-1-base]-Xanthine compounds, its preparation method and the purposes as pharmaceutical preparation BOEHRINGER INGELHEIM PHARMACEUTICAL CO., LTD. (DE) 2015-11-18 — — CN disclosed
CN-105001222-A New 8-(3-amino-piperidin-1-yl)-xanthine derivatives, preparing method and uses thereof as a pharmaceutic preparation BOEHRINGER INGELHEIM PHARMA 2015-10-28 — — CN disclosed
CN-101503409-B 8-(3-amino-piperidin-1-yl)-xanthines, the production thereof and the use of the same as medicaments BOEHRINGER INGELHEIM PHARMA 2014-01-22 — — CN disclosed
CN-101503408-B 8-(3-amino-piperidin-1-yl)-xanthines BEOEHRINGER INGELHEIM PHARMA GMBH & CO KG 2013-04-24 — — CN disclosed
CN-102964347-A 8-[3-amino-piperidin-1-yl]-xanthines, the production thereof and the use of the same as medicaments BOEHRINGER INGELHEIM PHARMA 2013-03-13 — — CN disclosed
CN-101503408-A 8-(3-amino-piperidin-1-yl)-xanthines BOEHRINGER INGELHEIM PHARMA (DE) 2009-08-12 — — CN disclosed
CN-101503409-A 8-(3-amino-piperidin-1-yl)-xanthines, the production thereof and the use of the same as medicaments BOEHRINGER INGELHEIM PHARMA (DE) 2009-08-12 — — CN disclosed
CN-100522962-C 8- [ 3-amino-piperidin-1-yl ] -xanthines, process for their preparation and their use as pharmaceutical preparations BOEHRINGER INGELHEIM PHARMA (DE) 2009-08-05 — — CN disclosed
CN-1675212-A 8- [ 3-amino-piperidin-1-yl ] -xanthines, process for their preparation and their use as pharmaceutical preparations BOEHRINGER INGELHEIM PHARMA (DE) 2005-09-28 — — CN disclosed
Send feedback